Image

Unlocking Opportunities in Latin America: Trends, Membership, and Annual Meeting Insights

Wednesday, July 24, 2024 at 10:00AM ET

Image

Download DIA's Patient Engagement Study Findings

DIA conducted a study in collaboration with the Tufts Center for the Study of Drug Development (CSDD) and found that 65 percent of pharmaceutical and biotech companies surveyed are investing in patient-centric initiatives in drug development.

Reported benefits include: reduced screen failure rates, faster patient recruitment, improved subject retention, reduced protocol amendments, and a greater number of patient relevant endpoints. In the study, cost to conduct, ease of conducting, and reported impact were measured.

Tools and resources included in the DIA Patient Engagement Study Findings:

  • Executive Summary of the study results and key insights
  • Considerations Guide to implementing patient-centric initiatives
Image

Lorem ipsum dolor sit amet consectetur adipisicing elit. Odit vero harum distinctio autem?

Lorem ipsum dolor sit amet consectetur adipisicing elit. Quam laborum reprehenderit amet in rerum id eum harum qui quos. A est consequatur reprehenderit necessitatibus repudiandae quia harum dolorum praesentium temporibus?

Form Title

Lorem ipsum dolor sit. Lorem ipsum dolor sit amet.

Lorem ipsum dolor sit. Lorem ipsum dolor sit amet.

Lorem ipsum dolor sit. Lorem ipsum dolor sit amet.

Lorem ipsum dolor sit amet consectetur adipisicing elit. Libero pariatur, illum iure sapiente eveniet, eos eligendi numquam aliquam, asperiores ea sit tempora praesentium aliquid dolore cumque animi omnis autem voluptas!

Lorem ipsum dolor sit amet consectetur.

Lorem ipsum dolor sit amet consectetur adipisicing elit. Consectetur, similique enim? Deserunt, quos eos! Vel aut magnam officia labore quo, laborum deserunt veritatis iste, molestias, illum alias voluptate debitis perspiciatis?

  • Lorem ipsum dolor sit.
  • Lorem ipsum dolor sit amet consectetur.
  • Lorem ipsum dolor sit amet consectetur adipisicing elit.

Video Title Lorem ipsum dolor sit amet.